BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22995620)

  • 1. Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitors.
    Miller MM; Liu Y; Jiang J; Johnson JA; Kamau M; Nirschl DS; Wang Y; Harikrishnan L; Taylor DS; Chen AY; Yin X; Seethala R; Peterson TL; Zvyaga T; Zhang J; Huang CS; Wexler RR; Poss MA; Lawrence RM; Adam LP; Salvati ME
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6503-8. PubMed ID: 22995620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitors.
    Wang Y; Yang W; Finlay HJ; Harikrishnan LS; Jiang J; Kamau MG; Van Kirk K; Nirschl DS; Taylor DS; Chen AY; Yin X; Sleph PG; Yang RZ; Huang CS; Adam LP; Lawrence RM; Wexler RR; Salvati ME
    Bioorg Med Chem Lett; 2014 Feb; 24(3):860-4. PubMed ID: 24424134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitors.
    Harikrishnan LS; Finlay HJ; Qiao JX; Kamau MG; Jiang J; Wang TC; Li J; Cooper CB; Poss MA; Adam LP; Taylor DS; Chen AY; Yin X; Sleph PG; Yang RZ; Sitkoff DF; Galella MA; Nirschl DS; Van Kirk K; Miller AV; Huang CS; Chang M; Chen XQ; Salvati ME; Wexler RR; Lawrence RM
    J Med Chem; 2012 Jul; 55(13):6162-75. PubMed ID: 22650305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Arylbenzoxazoles as CETP inhibitors: substitution and modification of the alpha-alkoxyamide moiety.
    Hunt JA; Gonzalez S; Kallashi F; Hammond ML; Pivnichny JV; Tong X; Xu SS; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Sparrow CP; Wright SD; Sinclair PJ
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1019-22. PubMed ID: 20036121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.
    Chen M; Yang X; Lai X; Gao Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4487-95. PubMed ID: 26346366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesteryl ester transfer protein (CETP) inhibitors based on cyclic urea, bicyclic urea and bicyclic sulfamide cores.
    Liu J; Shao PP; Guiadeen D; Krikorian A; Sun W; Deng Q; Cumiskey AM; Duffy RA; Murphy BA; Mitra K; Johns DG; Duffy JL; Vachal P
    Bioorg Med Chem Lett; 2021 Jan; 32():127668. PubMed ID: 33161125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitors.
    Jiang J; Finlay H; Johnson JA; Harikrishnan L; Kamau M; Qiao J; Wang T; Adam L; Taylor D; Yang R; Sleph P; Chen AYA; Yin X; Wexler R; Salvati ME
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3278-3281. PubMed ID: 27256912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromanol derivatives--a novel class of CETP inhibitors.
    Vakalopoulos A; Schmeck C; Thutewohl M; Li V; Bischoff H; Lustig K; Weber O; Paulsen H; Elias H
    Bioorg Med Chem Lett; 2011 Jan; 21(1):488-91. PubMed ID: 21084191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tetrahydrochinoline derived CETP inhibitors.
    Schmeck C; Gielen-Haertwig H; Vakalopoulos A; Bischoff H; Li V; Wirtz G; Weber O
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1740-3. PubMed ID: 20137927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety.
    Smith CJ; Ali A; Chen L; Hammond ML; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Sparrow CP; Wright SD; Sinclair PJ
    Bioorg Med Chem Lett; 2010 Jan; 20(1):346-9. PubMed ID: 19914065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors.
    Wang A; Prouty CP; Pelton PD; Yong M; Demarest KT; Murray WV; Kuo GH
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1432-5. PubMed ID: 20089400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesis.
    Harikrishnan LS; Kamau MG; Herpin TF; Morton GC; Liu Y; Cooper CB; Salvati ME; Qiao JX; Wang TC; Adam LP; Taylor DS; Chen AY; Yin X; Seethala R; Peterson TL; Nirschl DS; Miller AV; Weigelt CA; Appiah KK; O'Connell JC; Michael Lawrence R
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2640-4. PubMed ID: 18374566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors.
    Eary CT; Jones ZS; Groneberg RD; Burgess LE; Mareska DA; Drew MD; Blake JF; Laird ER; Balachari D; O'Sullivan M; Allen A; Marsh V
    Bioorg Med Chem Lett; 2007 May; 17(9):2608-13. PubMed ID: 17331716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.
    Kallashi F; Kim D; Kowalchick J; Park YJ; Hunt JA; Ali A; Smith CJ; Hammond ML; Pivnichny JV; Tong X; Xu SS; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Cumiskey AM; Latham M; Peterson LB; Rosa R; Sparrow CP; Wright SD; Sinclair PJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):558-61. PubMed ID: 21094047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.
    Kappelle PJ; van Tol A; Wolffenbuttel BH; Dullaart RP
    Cardiovasc Ther; 2011 Dec; 29(6):e89-99. PubMed ID: 20645987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors.
    Castilho MS; Guido RV; Andricopulo AD
    Bioorg Med Chem; 2007 Sep; 15(18):6242-52. PubMed ID: 17604633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and biophysical insight into cholesteryl ester-transfer protein.
    Hall J; Qiu X
    Biochem Soc Trans; 2011 Aug; 39(4):1000-5. PubMed ID: 21787337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform.
    Rano TA; Sieber-McMaster E; Pelton PD; Yang M; Demarest KT; Kuo GH
    Bioorg Med Chem Lett; 2009 May; 19(9):2456-60. PubMed ID: 19339179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and Biological Evaluation of N,N-Substituted Amine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors.
    Wang X; Hao L; Xu X; Li W; Liu C; Zhao D; Cheng M
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28972557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile entry to an efficient and practical enantioselective synthesis of a polycyclic cholesteryl ester transfer protein inhibitor.
    Han ZS; Xu Y; Fandrick DR; Rodriguez S; Li Z; Qu B; Gonnella NC; Sanyal S; Reeves JT; Ma S; Grinberg N; Haddad N; Krishnamurthy D; Song JJ; Yee NK; Pfrengle W; Ostermeier M; Schnaubelt J; Leuter Z; Steigmiller S; Däubler J; Stehle E; Neumann L; Trieselmann T; Tielmann P; Buba A; Hamm R; Koch G; Renner S; Dehli JR; Schmelcher F; Stange C; Mack J; Soyka R; Senanayake CH
    Org Lett; 2014 Aug; 16(16):4142-5. PubMed ID: 25084526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.